Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingfukang Granule is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of cervical spondylosis. It is indicated for patients presenting with symptoms associated with rheumatism and blood stasis syndrome, such as neck and shoulder pain, numbness in the limbs, and dizziness. The formula typically contains a complex mixture of herbal ingredients including *Notopterygium incisum*, *Ligusticum chuanxiong*, *Pueraria lobata*, and *Angelica sinensis*. It works by promoting blood circulation, removing blood stasis, and expelling wind and cold to relieve pain. It is widely used in China and has been the subject of real-world clinical studies to evaluate its efficacy and safety in multi-center settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jingfukang Granule.